Swamy M Anjaneya, Malhotra Bharti, Reddy P V Janardhan, Kumar Neeraj, Tiwari Jitendra Kumar, Gupta M L
Department of Microbiology & Immunology, Advanced Basic Sciences & Clinical Research Laboratory, (ICMR Grade - I Viral Diagnostics & Research Laboratory), Sawai Man Singh Medical College, Jawahar Lal Nehru Marg, Jaipur, 302004, Rajasthan, India.
Department of Medicine Pediatrics, J. K. Lone Hospital, Jaipur, Rajasthan, India.
Indian J Pediatr. 2016 Oct;83(10):1109-13. doi: 10.1007/s12098-016-2139-6. Epub 2016 May 13.
To study the distribution of Human Parainfluenza viruses (HPIV) 1-4 and their trends in children ≤5 y of age, hospitalised at a tertiary care centre, Jaipur and co-infection with other respiratory viruses.
Nasopharyngeal aspirate and throat swabs were collected and processed for extraction of nucleic acid using automated extraction system and real time RT-PCR was performed using primers and probes specific to HPIV 1-4 and other respiratory viruses on 743 samples.
Total positivity for Parainfluenza viruses 1-4 was found to be 69/743 (9.28 %), of which 50/533 (9.38 %) were boys and 19/210 (9.05 %) girls. Predominance of HPIV- 3 was observed [41/743 (5.52%)] followed by HPIV-1 in 13/743 (1.75%), HPIV-4 in 10/743 (1.34%) and HPIV-2 in 5/743 (0.67%) patients. Maximum positivity was observed in age group 25-36 mo (12.98%) followed by 13-24 mo group (11.96%). HPIVs were found to be circulating round the year and each year. Co-infections with other respiratory viruses were observed in 22/69 (31.88%) of HPIV positive patients.
All the four types of HPIV were found to be circulating in the index population during all the three years, predominantly during post monsoon and winter seasons. HPIV vaccination should be targeted for all types.
研究在斋浦尔一家三级医疗中心住院的5岁及以下儿童中人副流感病毒(HPIV)1 - 4的分布情况及其变化趋势,以及与其他呼吸道病毒的合并感染情况。
采集鼻咽抽吸物和咽拭子,使用自动提取系统进行核酸提取,并对743份样本使用针对HPIV 1 - 4和其他呼吸道病毒的引物和探针进行实时逆转录聚合酶链反应(RT-PCR)。
发现副流感病毒1 - 4的总阳性率为69/743(9.28%),其中男孩50/533(9.38%),女孩19/210(9.05%)。观察到HPIV - 3占主导地位[41/743(5.52%)],其次是HPIV - 1为13/743(1.75%),HPIV - 4为10/743(1.34%),HPIV - 2为5/743(0.67%)的患者。在25 - 36月龄年龄组中观察到最高阳性率(12.98%),其次是13 - 24月龄组(11.96%)。发现HPIV全年均有传播且每年如此。在69例HPIV阳性患者中有22例(31.88%)观察到与其他呼吸道病毒的合并感染。
在所有三年中,所有四种类型的HPIV均在研究人群中传播,主要在季风后和冬季季节。应针对所有类型进行HPIV疫苗接种。